<SEC-DOCUMENT>0001104659-17-004287-index.html : 20170126 <SEC-HEADER>0001104659-17-004287.hdr.sgml : 20170126 <ACCEPTANCE-DATETIME>20170126160215 ACCESSION NUMBER: 0001104659-17-004287 CONFORMED SUBMISSION TYPE: S-3 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20170126 DATE AS OF CHANGE: 20170126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-215747 FILM NUMBER: 17549708 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>S-3 <SEQUENCE>1 <FILENAME>a17-3162_1s3.htm <DESCRIPTION>S-3 <TEXT> Document 1 - file: a17-3162_1s3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.13 <SEQUENCE>2 <FILENAME>a17-3162_1ex4d13.htm <DESCRIPTION>EX-4.13 <TEXT> Document 2 - file: a17-3162_1ex4d13.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>a17-3162_1ex5d1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 3 - file: a17-3162_1ex5d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>4 <FILENAME>a17-3162_1ex23d1.htm <DESCRIPTION>EX-23.1 <TEXT> Document 4 - file: a17-3162_1ex23d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g31621kg03i001.gif <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: g31621kg03i001.gif
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g31621kg01i001.gif <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g31621kg01i001.gif
</DOCUMENT> </SEC-DOCUMENT>